1.
Bioorg Med Chem Lett
; 20(10): 3142-5, 2010 May 15.
Article
in English
| MEDLINE
| ID: mdl-20392638
ABSTRACT
A series of N-(2-amino-5-substituted phenyl)benzamides (3-21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl)benzamide (6).